Product Information
PREGABALIN 300 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0644 per EA under NDC 67877046905. Its NADAC has been published 231 times since Mar 23, 2022.
FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877046905
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA207799FDA Approved
7/19/2019
TE Code
AB
On Market Since
7/21/2019
Price Statistics
The NADAC for PREGABALIN 300 MG CAPSULE has been published 231 times since Mar 23, 2022, and over the history we have for it it has declined 47.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0644 per EA |
|---|---|
| All-time high | $0.1218 (Apr 13, 2022) |
| All-time low | $0.0628 (Nov 20, 2024) |
| 52-week high | $0.0784 |
| 52-week low | $0.0644 |
| Median price | $0.0864 |
| Average price | $0.0867 |
| Largest weekly change | +30.8% (Aug 21, 2024) |
| Weeks tracked | 231 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PREGABALIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 300 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.0644 per EA (NDC 67877046905), effective Aug 19, 2026.
How has the price of PREGABALIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 300 MG CAPSULE has declined 47.1%. It has been tracked across 231 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for PREGABALIN 300 MG CAPSULE?
Since Mar 23, 2022, the NADAC for PREGABALIN 300 MG CAPSULE has ranged from a low of $0.0628 (Nov 20, 2024) to a high of $0.1218 (Apr 13, 2022), with a median of $0.0864 per EA.
Are there cheaper alternatives to PREGABALIN 300 MG CAPSULE?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PREGABALIN 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PREGABALIN 300 MG CAPSULE?
PREGABALIN 300 MG CAPSULE (NDC 67877046905) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.